(Q52899161)

9 May 2018

title

Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions. (English)

1 reference

9 May 2018

1 reference

3

1 reference

9 May 2018

Thomas Zobel

6

1 reference

9 May 2018

Dirk Lassner

7

1 reference

9 May 2018

Wolfgang Poller

5

object named as

Wolfgang Poller

1 reference

9 May 2018

author name string

Tanja Pozzuto

1

1 reference

9 May 2018

Kristina von Kietzell

2

1 reference

9 May 2018

Caroline Schmidt-Lucke

4

1 reference

9 May 2018

Heinz Zeichhardt

8

1 reference

9 May 2018

Stefan Weger

9

1 reference

9 May 2018

Henry Fechner

10

1 reference

9 May 2018

language of work or name

English

0 references

publication date

13 January 2011

1 reference

9 May 2018

published in

Virology

1 reference

9 May 2018

volume

411

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

50-64

1 reference

9 May 2018

Experimental parvoviral infection in humans

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Human parvovirus B19-associated myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Erythrocyte P antigen: cellular receptor for B19 parvovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Activation domain–mediator interactions promote transcription preinitiation complex assembly on promoter DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Firefly luciferase gene: structure and expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

A novel tetracycline-controlled transactivator-transrepressor system enables external control of oncolytic adenovirus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

7 January 2021

Human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Molecular pathology of inflammatory cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Adenovirus E1A gene autorepression: revertants of an E1A promoter mutation encode altered E1A proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Replication of the B19 parvovirus in human bone marrow cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Placental endothelial cells can be productively infected by Parvovirus B19.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

A cascade of adenovirus early functions is required for expression of adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Vector expression of adenovirus type 5 E1a proteins: evidence for E1a autoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Identification and characterization of two internal cleavage and polyadenylation sites of parvovirus B19 RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Construction and sequencing of an infectious clone of the human parvovirus B19.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

7 January 2021

Parvovirus B19: a new emerging pathogenic agent of inflammatory cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

7 January 2021

Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

7 January 2021

Novel transcription map for the B19 (human) pathogenic parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.019

7 January 2021

10.1016/J.VIROL.2010.12.019

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018